Trinity Biotech Attending 84th Scientific Sessions of the American Diabetes Association
10 Juin 2024 - 3:10PM
Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a commercial
stage biotechnology company focused on diabetes management
solutions and human diagnostics, including wearable biosensors,
announces that its senior management team plans to attend the 84th
Scientific Sessions of the American Diabetes Association in Orlando
Florida, taking place on June 21-24, 2024.
Management plans to host meetings with key
stakeholders and potential partners as it works to advance the next
generation of its recently acquired continuous glucose monitoring
(CGM) biosensor technology. Interested parties are invited to reach
out for more information by emailing Biosensors@trinitybiotech.com.
To learn more about Trinity’s CGM, please visit
https://cgm.trinitybiotech.com
About Trinity Biotech Trinity
Biotech is a commercial stage biotechnology company focused on
diabetes management solutions and human diagnostics, including
wearable biosensors. The Company develops, acquires, manufactures
and markets diagnostic systems, including both reagents and
instrumentation, for the point-of-care and clinical laboratory
segments of the diagnostic market and has recently entered the
wearable biosensor industry, with the acquisition of the biosensor
assets of Waveform Technologies Inc. and intends to develop a range
of biosensor devices and related services, starting with a
continuous glucose monitoring product. The products are used to
detect infectious diseases and to quantify the level of Haemoglobin
A1c and other chemistry parameters in serum, plasma and whole
blood. Trinity Biotech sells direct in the United States, Germany,
France and the U.K. and through a network of international
distributors and strategic partners in over 75 countries worldwide.
For further information, please see the Company's website:
www.trinitybiotech.com
Contact: |
Trinity Biotech plcGary Keating,
Ph.D.(353)-1-2769800 |
LifeSci Partners, LLCEric
Ribner(1)-646-751-4363E-mail:
investorrelations@trinitybiotech.com |
Trinity Biotech (NASDAQ:TRIB)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Trinity Biotech (NASDAQ:TRIB)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024